Progress in retinal and eye research · 2026
Stromal Transplantation and corneal-sparing techniques in ectatic diseases.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hayashi Takahiko, Igarashi Ami, Fujiwara Kyohei, Kobashi Hidenaga, Son Hyeck-Soo, Kling Sabine, Morishige Naoyuki, Yamagami Satoru, Tran Khoa D, Moramarco Antonio, Hafezi Farhad, Perk Fatma Feyza Nur Keskin, Kılıç Aylin, Fernández-Vega-Cueto Luis, Madrid-Costa David, Baydoun Lamis, Melles Gerrit, Nubile Mario, Alio Del Barrio Jorge, Romano Vito
Аннотация
Corneal ectatic and degenerative disorders have traditionally been managed with tissue-replacement strategies such as penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK). However, an improved understanding of corneal biomechanics, stromal wound healing, and immune privilege has driven a paradigm shift toward tissue-sparing and layer-selective interventions. In particular, biologically integrated stromal procedures, including Bowman layer transplantation (BLT), corneal allogenic intrastromal ring segments (CAIRS), and stromal lenticule addition keratoplasty (SLAK), aim to restore structural integrity, improve corneal shape, and preserve native tissue while minimising the risks associated with full-thickness transplantation. In this review, we summarise the structural basis of corneal biomechanics, the pathological mechanisms of stromal failure in keratoconus and related disorders, and the biological responses that follow stromal interventions. We then evaluate current evidence on corneal cross-linking (CXL), stromal reinforcement, and stromal addition procedures, with emphasis on indications, mechanisms, clinical outcomes, and limitations. Reflecting this evolution, we frame these procedures as the restoration of specific biomechanical and optical functions rather than mere tissue replacement, aligning corneal surgery with the broader trend toward selective tissue restoration and minimally invasive biological augmentation. To support clinical decision-making, we propose a three-tier Stabilise-Reshape-Replace (SRR) framework. Each tier addresses a dominant clinical problem: SRR is intended as a pragmatic expert-derived scaffold rather than a validated treatment algorithm.